Literature DB >> 24333166

Early markers of neural dysfunction and compensation: a model from minimal hepatic encephalopathy.

Giorgia Cona1, Sara Montagnese2, Patrizia Silvia Bisiacchi3, Angelo Gatta4, Umberto Cillo5, Paolo Angeli6, Piero Amodio7, Sami Schiff8.   

Abstract

OBJECTIVE: The Inhibitory Control Task (ICT) was used to detect minimal hepatic encephalopathy (MHE). ICT assesses attention, working memory and inhibition by evaluating performance in detect, go and nogo trials, respectively. The event-related potentials (ERPs) elicited by the ICT provide insight into neural mechanisms underlying the cognitive alterations associated with MHE.
METHODS: The performance and the ERPs elicited by ICT were measured in 31 patients with cirrhosis (13 with and 18 without MHE) and in 17 controls. The latency and amplitude of the N2, P3a, P3b and nogo-P3 were compared among the groups.
RESULTS: Patients with MHE performed worse in all ICT trials compared to patients without MHE and controls. Cirrhotic patients, both with and without MHE, displayed a reduction in P3a amplitude, selectively in the detect trials. Patients without MHE exhibited greater N2 and nogo-P3 amplitudes compared to patients with MHE and controls.
CONCLUSIONS: Both patients with and without MHE displayed neural alterations reflecting attentional deficits (i.e., P3a attenuation). However, patients without MHE coped with such dysfunctions by recruiting compensatory neural mechanisms, as suggested by the enhancement of the nogo-P3 and N2 amplitudes coupled with a normal ICT performance. SIGNIFICANCE: The study suggests how initial brain dysfunction might be compensated for by recruitment of additional neurocognitive resources.
Copyright © 2013 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Compensation; Event-related potentials; Inhibition; Minimal hepatic encephalopathy; N2; P3

Mesh:

Substances:

Year:  2013        PMID: 24333166     DOI: 10.1016/j.clinph.2013.10.048

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  5 in total

1.  Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosis-related symptoms and a history of overt hepatic encephalopathy.

Authors:  Emi Yoshimura; Tatsuki Ichikawa; Hisamitsu Miyaaki; Naota Taura; Satoshi Miuma; Hidataka Shibata; Takuya Honda; Fuminao Takeshima; Kazuhiko Nakao
Journal:  Biomed Rep       Date:  2016-06-13

Review 2.  Qualifying and quantifying minimal hepatic encephalopathy.

Authors:  Marsha Y Morgan; Piero Amodio; Nicola A Cook; Clive D Jackson; Gerald Kircheis; Mette M Lauridsen; Sara Montagnese; Sami Schiff; Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2015-09-28       Impact factor: 3.584

Review 3.  Clinical neurophysiology of hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese
Journal:  J Clin Exp Hepatol       Date:  2014-08-03

4.  It's a Matter of Mind! Cognitive Functioning Predicts the Athletic Performance in Ultra-Marathon Runners.

Authors:  Giorgia Cona; Annachiara Cavazzana; Antonio Paoli; Giuseppe Marcolin; Alessandro Grainer; Patrizia Silvia Bisiacchi
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

5.  Cognitive Impairment After Resolution of Hepatic Encephalopathy: A Systematic Review and Meta-Analysis.

Authors:  Óscar López-Franco; Jean-Pascal Morin; Albertina Cortés-Sol; Tania Molina-Jiménez; Diana I Del Moral; Mónica Flores-Muñoz; Gabriel Roldán-Roldán; Claudia Juárez-Portilla; Rossana C Zepeda
Journal:  Front Neurosci       Date:  2021-03-10       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.